| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | Australia | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Hungary | 2 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Combinatorial chemistry | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Himmler Gottfried | 13 |
| #2 | Wozniak-Knopp Gordana | 8 |
| #3 | Ruker Florian | 6 |
| #4 | Redl Gerda | 5 |
| #5 | Mudde Geert | 4 |
| #6 | Wozniak Knopp Gordana | 3 |
| #7 | Bauer Anton | 3 |
| #8 | Rueker Florian | 3 |
| #9 | Woisetschlaeger Maximilian | 2 |
| #10 | Kinmei Leung | 1 |
| Publication | Filing date | Title |
|---|---|---|
| BR112016007348A2 | specific binding member that binds to human epidermal growth factor 2 receptor (her2) for use in a patient cancer treatment method, a patient cancer treatment method, a patient cancer identification method , method to predict cancer response |